BioCentury
ARTICLE | Company News

TetraLogic names Buchi president, CEO

August 19, 2013 11:30 PM UTC

Cancer company TetraLogic Pharmaceuticals (Malvern, Pa.) hired J. Kevin Buchi as president and CEO. He succeeds TetraLogic Co-Founder John Gill, who will remain a director. Buchi was VP of global branded products at Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) and prior to that was CEO of Cephalon Inc., which Teva acquired in 2011.

TetraLogic also hired Lesley Russell as COO and Pete Meyers as CFO. Russell was SVP and global head of R&D of global branded products at Teva, and was EVP and CMO at Cephalon. Meyers was a managing director, co-head of global health care investment banking at Deutsche Bank. ...